LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 118 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,713,000 | -53.2% | 462,296 | -72.7% | 0.01% | -50.0% |
| Q4 2020 | $5,793,000 | +117.0% | 1,694,035 | -8.6% | 0.02% | +100.0% |
| Q3 2020 | $2,669,000 | -19.5% | 1,854,310 | +11.5% | 0.01% | -21.4% |
| Q2 2020 | $3,315,000 | +57.9% | 1,662,926 | +54.5% | 0.01% | +16.7% |
| Q1 2020 | $2,099,000 | +206.4% | 1,076,061 | +552.4% | 0.01% | +300.0% |
| Q4 2019 | $685,000 | +678.4% | 164,948 | +3275.9% | 0.00% | – |
| Q3 2016 | $88,000 | -89.8% | 4,886 | -91.9% | 0.00% | -100.0% |
| Q2 2016 | $863,000 | – | 60,136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |